Abstract
ABSTRACTThe aerodigestive tract (ADT) is the primary portal through which pathogens and other invading microbes enter the body. As the direct interface with the environment, we hypothesize that the ADT microbiota possess biosynthetic gene clusters (BGCs) for antibiotics and other specialized metabolites to compete with both endogenous and exogenous microbes. From 1,214 bacterial genomes, representing 136 genera and 387 species that colonize the ADT, we identified 3,895 BGCs. To determine the distribution of BGCs and bacteria in different ADT sites, we aligned 1,424 metagenomes, from nine different ADT sites, onto the predicted BGCs. We show that alpha diversity varies across the ADT and that each site is associated with distinct bacterial communities and BGCs. We identify specific BGC families enriched in the buccal mucosa, external naris, gingiva, and tongue dorsum despite these sites harboring closely related bacteria. We reveal BGC enrichment patterns indicative of the ecology at each site. For instance, aryl polyene and resorcinol BGCs are enriched in the gingiva and tongue, which are colonized by many anaerobes. In addition, we find that streptococci colonizing the tongue and cheek possess different ribosomally synthesized and posttranslationally modified peptide BGCs. Finally, we highlight bacterial genera with BGCs but are underexplored for specialized metabolism and demonstrate the bioactivity of Actinomyces against other bacteria, including human pathogens. Together, our results demonstrate that specialized metabolism in the ADT is extensive and that by exploring these microbiomes further, we will better understand the ecology and biogeography of this system and identify new bioactive natural products.IMPORTANCE Bacteria produce specialized metabolites to compete with other microbes. Though the biological activities of many specialized metabolites have been determined, our understanding of their ecology is limited, particularly within the human microbiome. As the aerodigestive tract (ADT) faces the external environment, bacteria colonizing this tract must compete both among themselves and with invading microbes, including human pathogens. We analyzed the genomes of ADT bacteria to identify biosynthetic gene clusters (BGCs) for specialized metabolites. We found that the majority of ADT BGCs are uncharacterized and the metabolites they encode are unknown. We mapped the distribution of BGCs across the ADT and determined that each site is associated with its own distinct bacterial community and BGCs. By further characterizing these BGCs, we will inform our understanding of ecology and biogeography across the ADT, and we may uncover new specialized metabolites, including antibiotics.
Highlights
The aerodigestive tract (ADT) is the primary portal through which pathogens and other invading microbes enter the body
We characterized the potential for specialized metabolism of ADT microbiomes by identifying biosynthetic gene clusters (BGCs) from the ADT bacteria and surveying how these BGCs are distributed across different sites in this multiorgan system
We find that human ADT microbiomes possess extensive potential for the biosynthesis of specialized metabolites and other bioactive natural products and demonstrate bioactivity from Actinomyces, a bacterial genus that has been underexplored for specialized metabolism
Summary
The aerodigestive tract (ADT) is the primary portal through which pathogens and other invading microbes enter the body. Within the GI tracts of humans and other animals, colonization resistance against pathogens mediated by the endemic microbiota involves exploitation through niche occlusion [8] and interference, including type VI secretion systems [9] and production of metabolites [10]. In bacteria and other microbes, the genes responsible for production of specialized metabolites are organized in genomic loci called biosynthetic gene clusters (BGCs). By following the biosynthetic logic for nonribosomal peptides, total chemical synthesis was used to produce the antibiotic humimycins encoded by Rhodococcus species genomes [15] Together, these and other examples have led to a newfound appreciation of the biosynthetic potential of animal microbiomes for the identification of new bioactive natural products [16,17,18,19,20]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.